103 related articles for article (PubMed ID: 34949180)
1. A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway.
Wang X; Xiong T; Cui M; Li N; Li Q; Zhu L; Duan S; Wang Y; Guo Y
J Nanobiotechnology; 2021 Dec; 19(1):444. PubMed ID: 34949180
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles.
Lu Q; Gao W; Chen Z; Liu Z; Wang J; Zeng L; Hu X; Zheng E; Zhang Q; Song H
Int J Pharm; 2024 Apr; 655():124028. PubMed ID: 38518871
[TBL] [Abstract][Full Text] [Related]
3. The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer.
McFadden M; Singh SK; Kinnel B; Varambally S; Singh R
J Ovarian Res; 2023 Nov; 16(1):220. PubMed ID: 37990267
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Nanosystems on ATP-Binding Cassette Transporters: Understanding the Influence of Nanosystems on Multidrug Resistance Protein-1 and P-glycoprotein.
Mello FVC; de Moraes GN; Maia RC; Kyeremateng J; Iram SH; Santos-Oliveira R
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290047
[TBL] [Abstract][Full Text] [Related]
5. A convenient protonated strategy for constructing nanodrugs from hydrophobic drug-inhibitor conjugates to reverse tumor multidrug resistance.
Wang P; Wang Y; Xia X; Wu J; Lin J; Huang W; Yan D
Nanoscale; 2024 May; 16(17):8434-8446. PubMed ID: 38592819
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein antibody-conjugated paclitaxel liposomes targeted for multidrug-resistant lung cancer.
Wang J; Suo X; Zhang H
Nanomedicine (Lond); 2023 Apr; 18(10):819-831. PubMed ID: 37306214
[No Abstract] [Full Text] [Related]
7. Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles induces proliferation inhibition and apoptosis in ovarian cancer cells.
Liu H; Chang S; Sun J; Zhu S; Pu C; Zhu Y; Wang Z; Xu RX
Mol Pharm; 2014 Jan; 11(1):40-8. PubMed ID: 24266423
[TBL] [Abstract][Full Text] [Related]
8. Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance.
Yu X; Yang G; Shi Y; Su C; Liu M; Feng B; Zhao L
Int J Nanomedicine; 2015; 10():7045-56. PubMed ID: 26648717
[TBL] [Abstract][Full Text] [Related]
9. Engineering extracellular vesicles mimetics for targeted chemotherapy of drug-resistant ovary cancer.
Liu X; Liu G; Mao Y; Luo J; Cao Y; Tan W; Li W; Yu H; Jia X; Li H
Nanomedicine (Lond); 2024 Jan; 19(1):25-41. PubMed ID: 38059464
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma.
Reddy TL; Garikapati KR; Reddy SG; Reddy BV; Yadav JS; Bhadra U; Bhadra MP
Sci Rep; 2016 Oct; 6():35223. PubMed ID: 27786239
[TBL] [Abstract][Full Text] [Related]
11. Multimodal Nanoplatform with ROS Amplification to Overcome Multidrug Resistance in Prostate Cancer via Targeting P-Glycoprotein and Ferroptosis.
Guan Y; Lei H; Xing C; Yan B; Lin B; Yang X; Huang H; Kang Y; Pang J
Adv Healthc Mater; 2024 Jan; 13(3):e2301345. PubMed ID: 37855250
[TBL] [Abstract][Full Text] [Related]
12. Novel (-)-arctigenin derivatives inhibit signal transducer and activator of transcription 3 phosphorylation and P-glycoprotein function resensitizing multidrug resistant cancer cells in vitro and in vivo.
Yu KH; Kuo CY; Wu IT; Chi CH; Tsai KC; Kuo PC; Zeng JW; Hung CC; Hung HY
Eur J Pharmacol; 2023 Dec; 960():176146. PubMed ID: 37884184
[TBL] [Abstract][Full Text] [Related]
13. The
Yin B; Lu P; Liang J; Zhang W; Xin M; Pei K; Li Y
J Int Med Res; 2019 Oct; 47(10):5256-5269. PubMed ID: 31638462
[TBL] [Abstract][Full Text] [Related]
14. Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles.
Rodzinski A; Guduru R; Liang P; Hadjikhani A; Stewart T; Stimphil E; Runowicz C; Cote R; Altman N; Datar R; Khizroev S
Sci Rep; 2016 Feb; 6():20867. PubMed ID: 26875783
[TBL] [Abstract][Full Text] [Related]
15. Targeted reversal of multidrug resistance in ovarian cancer cells using exosome‑encapsulated tetramethylpyrazine.
Zhao C; Qiu L; Wu D; Zhang M; Xia W; Lv H; Cheng L
Mol Med Rep; 2024 Feb; 29(2):. PubMed ID: 38099342
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.
Pessina A; Bonomi A; Coccè V; Invernici G; Navone S; Cavicchini L; Sisto F; Ferrari M; Viganò L; Locatelli A; Ciusani E; Cappelletti G; Cartelli D; Arnaldo C; Parati E; Marfia G; Pallini R; Falchetti ML; Alessandri G
PLoS One; 2011; 6(12):e28321. PubMed ID: 22205945
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional Nanosystem for Targeted and Controlled Delivery of Multiple Chemotherapeutic Agents for the Treatment of Drug-Resistant Breast Cancer.
Lou S; Zhao Z; Dezort M; Lohneis T; Zhang C
ACS Omega; 2018 Aug; 3(8):9210-9219. PubMed ID: 30197996
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice.
Alalawy AI; Sakran M; Alzuaibr FM; Alotaibi MA; El-Hefnawy ME; Hazazi AY; El-Gendy SM; Aidy EA; Effat H; Ismail DF; Hessien M
Sci Rep; 2023 Dec; 13(1):22782. PubMed ID: 38129495
[TBL] [Abstract][Full Text] [Related]
19. Suicide gene delivery by morphology-adaptable enantiomeric peptide assemblies for combined ovarian cancer therapy.
Song N; Sun Z; Wang B; Liu X; Hu B; Chen N; Zhang S; Yu Z
Acta Biomater; 2024 Feb; 175():250-261. PubMed ID: 38122884
[TBL] [Abstract][Full Text] [Related]
20. PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers.
Yu J; Hu F; Zhu Q; Li X; Ren H; Fan S; Qian B; Zhai B; Yang D
Nanoscale Res Lett; 2020 Mar; 15(1):59. PubMed ID: 32166458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
